Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, hydrochloride, mixt. with (7S-(7alpha,7aalpha,14alpha,14abeta))-dodecahydro-7,14-methano-2H,6H-dipyrido(1,2-a:1,2-e)(1,5)diazocine sulfate (1:1) and endo-(+-)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl-alpha-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt) (74662-02-5)
Identification |
Properties |
Safety Data |
|
|
Other Product
- Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with endo-(+-)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl alpha-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt), sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate and N,N,alpha-trimethyl-10H-phenothiazine-10-ethanamine
- Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl R-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt),sodium [(2,3-dihydro-1,5-dimethyl-3- oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]- methanesulfonate and N,N,R-trimethyl-10H-phenothiazine-10- ethanamine monohydrochloride
- Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-ethoxy-17-methyl-, hydrochloride, (5alpha,6alpha)-, mixt. with (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2,4))non-7-yl alpha-(hydroxymethyl)benzeneacetate hydrobromide and sodium (1S)-7,7-dimethyl-2-oxobicyclo(2.2.1)heptane-1-methane sulfonate
- 5-oxo-L-proline, compound with endo-()-8-methyl-8-azabicyclo[3.2.1]oct-3-yl α-(hydroxymethyl)benzeneacetate (1:2)
- Pyridinium,2-[(hydroxyimino)methyl]-1- methyl-,iodide,mixt. with 2-(diethylamino)ethyl R-hydroxy-R-phenylbenzeneacetate and (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl R-(hydroxymethyl)benzeneacetate
- 5-oxo-L-proline, compound with endo-()-8-methyl-8-azabicyclo[3.2.1]oct-3-yl α-(hydroxymethyl)benzeneacetate (1:1)
- Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-17-methyl-3-(2-(4-morpholinyl)ethoxy)-, (5alpha,6alpha)-, mixt. with (R*,S*)-(+-)-alpha-(1-aminoethyl)benzenemethanol and N-(4-hydroxyphenyl)acetamide
- Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid and N-(4-ethoxyphenyl)acetamide
- 5-oxo-L-proline, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine (2:1)
- 5-ethyl-5-phenylbarbituric acid, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine
- Benzeneacetic acid,R-(hydroxymethyl)- (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl ester,compounds,sulfate (1:1) (salt),mixt. with 1-[(3,4-dimethoxyphenyl)methyl]-6,7- dimethoxyisoquinoline sulfate (1:1)
- Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
- 8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2R)-3-hydroxy-2-phenylpropanoate sulfate (2:1)
- [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine dihydroiodide
- Ergotoxine,dihydro-,monomethanesulfonate (salt),mixt. with 1-[(3,4-dimethoxyphenyl)methyl]-6,7- dimethoxyisoquinoline hydrochloride and (7S,7aR,14S,14aS)-dodecahydro-7,14- methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]- diazocine monohydrochloride
- [7S-(7α,7aα,14α,14aβ)]-dodecahydro-5(or 12)-methyl-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocinium iodide
- Benzeneacetic acid, a-[4-(phenylmethoxy)butyl]-,8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, endo-, sulfate (1:1)
- Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-, (5alpha,6alpha)-, (5alpha,6alpha)-, di-3-pyridinecarboxylate (ester), hydrochloride, mixt. with (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-17-(2-propenyl)morphinan-3,6-diol di-3-pyridinecarboxylate (ester), monohydrchloride
- Morphinan-6-one,4,5-epoxy-14-hydroxy-3- methoxy-17-methyl-,hydrochloride,(5R)-,mixt. with (RS)-R-[(1R)-1-(methylamino)ethyl]- benzenemethanol hydrochloride and (1R,2â,4â,5R,7â)-9-methyl-3-oxa-9- azatricyclo[3.3.1.02,4]non-7-yl (RS)-R-(hydroxymethyl)benzeneacetate hydrobromide
- 5-ethyl-5-phenylbarbituric acid, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine (2:1)